Increasing physical function through physiatric intervention for children with paediatric neurotransmitter disorders

Area of Science:

• Neurology
• Paediatrics
• Rehabilitation Medicine

Background:

• Children with paediatric neurotransmitter diseases often experience global functional deficits due to central nervous system damage.
• Disordered muscle tone (spasticity, rigidity, dystonia) is a primary concern, leading to complications like skin breakdown, pain, sleep disturbance, and dysphagia.

Purpose of the Study:

• To present a framework and rationale for managing the functional consequences of paediatric neurotransmitter diseases.
• To outline strategies for improving physical function and maximizing independence in affected children.

Main Methods:

• A multi-disciplinary approach involving paediatric physiatrists.
• Pharmacological interventions including GABA-agonists (baclofen, benzodiazepines), alpha-2 adrenergic agonists, L-dopa, dopaminergic agents, and dantrolene.
• Other treatments such as intrathecal baclofen, botulinum toxin, phenol, selective dorsal rhizotomy, and tendon lengthening, alongside adaptive equipment and therapeutic exercise.

Main Results:

• Physiatrists can normalize muscle tone and improve body positioning to enhance physical function.
• Integrated treatment programs utilizing medications, equipment, therapy, and exercise maximize functional independence.
• Addressing complications of disordered tone is crucial for improving patient outcomes.

Conclusions:

• A comprehensive, integrated management strategy is essential for improving the quality of life for children with paediatric neurotransmitter diseases.
• Physiatrists play a key role in optimizing functional outcomes through a tailored, multi-modal treatment approach.
• Focusing on functional gains and independence is paramount in the care of these children.